Ventrus Biosciences Announces Exercise of Underwriters' Over-Allotment Option …
NEW YORK, Jul 19, 2011 (GlobeNewswire via COMTEX) — Ventrus Biosciences, Inc. ("Ventrus") /quotes/zigman/2380075/quotes/nls/vtus VTUS -0.08% , a pharmaceutical company focused on developing and commercializing gastrointestinal products, announced that …
See all stories on this topic »
